Home · Open Lab · Lot RGX-26-TESAMORELIN-1046
RGX-26-TESAMORELIN-1046Current
Tesamorelin · 10 MG · Endocrine Research · COA NS-2026-05047

Release test results

99.753%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.05 mg
Related impurities (total)0.247%
Endotoxin<1.0 EU/mg
HPLC retention time6.22 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundTesamorelin
Presentation10 MG
Lot numberRGX-26-TESAMORELIN-1046
COA numberNS-2026-05047
Test date06 Sep 2026
Release date09 Sep 2026
Independent labNordicstar Labs
StatusCurrent

Tesamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-TESAMORELIN-65410 MGSep 8, 202699.684%Superseded
RGX-26-TESAMORELIN-1046 this lot10 MGSep 6, 202699.753%Current
RGX-26-TESAMORELIN-75410 MGSep 6, 202699.736%Superseded
RGX-26-TESAMORELIN-75320 MGSep 6, 202699.646%Superseded
RGX-26-TESAMORELIN-65320 MGSep 5, 202699.667%Superseded
RGX-26-TESAMORELIN-104720 MGSep 4, 202699.584%Current
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →